Isolation, Social
12
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (12)
Human Milk Oligosaccharides (HMOs) and Gut Microbiota, Immune System in Antarctica
Brain Changes in Response to Long-Duration Isolation and Confinement
Impact of the HELPeN Program on Social Isolation in Community-dwelling Elders (HELPeN)
Reciprocal Benefit by Intergenerational Meetings
Creating a Virtual Village for People Aging With HIV During COVID-19
COVID-19 Pandemic: Effect on Management of Patients With Breast Cancer
Sleep Behaviour in Athletes During Home Confinement Due to the Covid-19 Outbreak
Diabetes Outcomes in COVID-19 Pandemic
Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives
Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers
Psychiatric Consultation for COVID-19 Patients
Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19